957121-34-5 Usage
General Description
The chemical (R)-tert-butyl 2'-oxo-1'-((2-(trimethylsilyl)ethoxy)methyl)-1,1',2',3-tetrahydrospiro[indene-2,3'-pyrrolo[2,3-b]pyridine]-5-ylcarbamate is a complex compound that contains a spirocyclic structure with an indene-pyrrolo-pyridine core. It has a tert-butyl protecting group and a trimethylsilyl ether moiety. (R)-tert-butyl 2'-oxo-1'-((2-(trimethylsilyl)ethoxy)methyl)-1,1',2',3-tetrahydrospiro[indene-2,3'-pyrrolo[2,3-b]pyridine]-5-ylcarbamate is a carbamate derivative, which is a type of ester formed from carbonic acid and an organic amine. It has potential applications in medicinal chemistry, particularly in the development of pharmaceuticals targeting certain biological pathways. The specific activity and uses of this compound would depend on its biological properties and potential for binding to specific targets.
Check Digit Verification of cas no
The CAS Registry Mumber 957121-34-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,7,1,2 and 1 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 957121-34:
(8*9)+(7*5)+(6*7)+(5*1)+(4*2)+(3*1)+(2*3)+(1*4)=175
175 % 10 = 5
So 957121-34-5 is a valid CAS Registry Number.
957121-34-5Relevant articles and documents
IMIDAZOLINONE DERIVATIVES AS CGRP RECEPTOR ANTAGONISTS
-
Page/Page column 74, (2010/08/04)
The present invention is directed to imidazolinone derivatives which are antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which CGRP is involved, such as migraine. The invention is also directed to pharmaceutical comp
MONOCYCLIC ANILIDE SPIROLACTAM CGRP RECEPTOR ANTAGONISTS
-
, (2008/12/07)
The present invention is directed to compounds of Formula I: I (where variables A1, A2, B, J, K, m, n, R4, R5a, R5b and R5c are as defined herein) useful as antagonists of CGRP receptors an
CGRP RECEPTOR ANTAGONISTS WITH TERTIARY AMIDE, SULFONAMIDE, CARBAMATE AND UREA END GROUPS
-
Page/Page column 96, (2008/12/08)
Compounds of formula I: (I) (wherein variables A, m, n, J, Re, Rf, R4, Ea, Eb, Ec, RPG and Y are as described herein) which are antagonists of CGRP receptors and which are useful